Cancer Stem Cell Plasticity Drives Therapeutic Resistance - Test2 - elhamkhani - TriplyDB

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

http://www.wikidata.org/entity/Q26770274

about

Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy.Modelling collective cell migration of neural crest.Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer.The self-renewal signaling pathways utilized by gastric cancer stem cells.Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties.Comparison of tumor biology of two distinct cell sub-populations in lung cancer stem cells.Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity.Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment.Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer.miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.Wnt/β-catenin pathway activation mediates adaptive resistance to BRAF inhibition in colorectal cancer.The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.Characterisation of mesenchymal colon tumour-derived cells in tumourspheres as a model for colorectal cancer progression Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state

P2860

Q26740207-44D7D2C5-1602-4CCC-A8F2-BC58EE9F8483 Q26747513-17E6FBF9-89CA-4E2F-BDF4-43C15C65BF90 Q28066460-95A82BC6-C759-461E-B8FD-855B4F6E5A97 Q28818141-0EF7B55E-FF81-4900-A6ED-0CB2A79FCCD8 Q33737278-6416B074-92EA-4B62-99A9-C83E83E7A6C1 Q33833666-18B164B2-F6A1-4252-BD5E-D43A202A1821 Q33902576-EF763891-F0C4-4E03-AAFB-982AED033B95 Q37735617-AD0B8919-922A-4458-89A2-3F218BB0A11C Q38809848-D17ED475-C00A-4832-BA9D-4482C7500623 Q38950219-D352DFB9-0E70-4B4D-B15F-D0757A7CAA81 Q39039925-5835506E-E141-4E20-8B50-A252CE5AEA0D Q39221222-547A5CE7-169A-496C-950D-C9528F01A453 Q42330818-62EEBFD7-D10D-4F46-AACA-F0E6A1C8A849 Q47101870-890AABB3-5432-4063-A4E5-4535D447E7F1 Q47106862-3D31E752-4F21-46AE-A6A3-43B5089E66B0 Q47110103-CFD7B9D3-49F9-4594-9FA8-860286AC2F2A Q47133357-23367842-258E-47D8-B705-1EF40F769449 Q47304779-EBAB1E1B-B815-4DE4-81F4-FF0A89B969EE Q47725453-B88D0A63-C0BF-4B27-9ABB-8753A796A940 Q49209465-CD9290AB-99BE-4EA2-9C53-EA6ED127FE5B Q49788106-5BC6DA9D-47E3-44CE-9D56-9EC7431B963B Q52590861-0865F67F-ED47-4E6E-91B9-76FD7273BB2D Q55057314-8F7CCE69-EDFB-4B67-A814-C54E534C0263 Q57073897-1A82DEA2-CEFD-4F50-B67C-E2F7EAE5F492 Q58695612-12C90C4F-1850-4A08-9DC6-9DB0CEEA8DCF Q59136649-FF46C698-48E1-4B80-94C4-EA6C792BE243

P2860

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

http://www.wikidata.org/entity/Q26770274

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@ast

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@en

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@nl

type

label

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@ast

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@en

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@nl

prefLabel

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@ast

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@en

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@nl

P1433

Q26770274-94894428-6313-4EDA-B270-BF0B579F1641

P1476

Q26770274-474BA748-BE50-4ABF-9D5C-97C5043961DC

P2093

Q26770274-6B82F223-EF22-4297-9418-447FC5EF262D

Q26770274-937D169D-CFFF-4272-A977-533E2C46A7C9

Q26770274-C7E3556E-0AC7-4D3F-BCE5-3B628A37CA6C

Q26770274-CEDA073B-EC54-4531-89BA-C43EB75F13C6

P2860

Q26770274-007D2715-6F41-46C4-9062-259CE6EAA625

Q26770274-03A17A83-246A-481B-BA7F-4AEE7F6FFFCB

Q26770274-07324883-77D6-4DF6-828D-1FC2B0552EED

Q26770274-07C8283D-DC69-4ED9-937B-CC9ED4DD826D

Q26770274-08F22ED8-F612-4A0E-93D2-025430CE1867

Q26770274-0982656F-60C9-47BC-B6C1-A2C1C6ED1AF1

Q26770274-1613F8CF-8E2E-416E-B20D-A49EC9AF8873

Q26770274-174E9396-6B52-4853-86D6-583996D6C544

Q26770274-19BF4B46-7AE8-4C9B-AE6D-DFD4D6FC4D82

Q26770274-1B7B89A3-2699-4961-B41A-7DA7650CE9E0

P304

Q26770274-0616EBCE-994E-41AB-9914-6C1FC1B1C86B

P31

Q26770274-24F31152-755C-4B51-8DEC-16F7035FCE8D

P3181

Q26770274-1906BC68-94BE-4601-8150-2148842B7ADB

P356

Q26770274-5DC30238-F98B-42C7-A8EF-E1B89CCF2B60

P407

Q26770274-4E22CACD-DA00-41CC-B3EA-39236FAC327B

P433

Q26770274-D895CBD6-9B6E-426B-B79B-92F2A4188C70

P478

Q26770274-678C30CC-7E0C-4A40-AB01-BA7F5A3243A6

P577

Q26770274-9CA3F96D-9DB6-4C93-8F21-F838FFFC07B7

P5875

Q26770274-7AEBB7EF-7744-4A10-A945-2CAEFAF53A83

P698

Q26770274-F1AF234C-BAFC-421B-BFFE-DA0961F7D688

P932

Q26770274-16084C99-B98B-40EB-8018-1463B7F9DD13

P3181

P356

P1433

P1476

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

@en

P2093

Damian J Junk

http://www.w3.org/2001/XMLSchema#string

Jacob M Smigiel

http://www.w3.org/2001/XMLSchema#string

Mark W Jackson

http://www.w3.org/2001/XMLSchema#string

Mary R Doherty

http://www.w3.org/2001/XMLSchema#string

P2860

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance

Epithelial-mesenchymal plasticity in carcinoma metastasis

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy

Molecular mechanisms of epithelial-mesenchymal transition

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations

P304

8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

633708

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/CANCERS8010008

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289534843

http://www.w3.org/2001/XMLSchema#string

P698

26742077

http://www.w3.org/2001/XMLSchema#string

P932

4728455

http://www.w3.org/2001/XMLSchema#string